Results of micropulse cyclophotocoagulation in patients with early stages of primary open-angle glaucoma

PURPOSE . To evaluate the capabilities of micropulse transscleral cyclophotocoagulation (MP-TSCPC) in patients with early stages glaucoma. METHODS The study included 38 primary open-angle glaucoma who underwent MP-TSCPC SUPRA 810 (“Quantel Medical”, France) as surgical treatment. follow-up period averaged 17±11 months (from 6 to 30 months). Kaplan-Meier scale was used assess cumulative success laser RESULTS postoperative uneventful. One month after a significant hypotensive effect observed, averaging 41.5% from baseline. After months, continued persist and 36.1%. By 12 remained stable, IOP 16.0±3.5 mm Hg, which 31% No changes best corrected visual acuity (BCVA) were detected during observation period. Target intraocular pressure (IOP) achieved all cases. Optical coherence tomography perimetry findings stable or improved. CONCLUSION leads pronounced period, 20% 50%). An improvement quality life noted due cease reduction number instillations. Monitoring continues order develop practical recommendations for indications regimens